Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.
J Virol. 2023 Nov 30;97(11):e0164622. doi: 10.1128/jvi.01646-22. Epub 2023 Nov 2.
J Virol. 2023.
PMID: 37916834
Free PMC article.
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
McMahon M, O'Dell G, Tan J, Sárközy A, Vadovics M, Carreño JM, Puente-Massaguer E, Muramatsu H, Bajusz C, Rijnink W, Beattie M, Tam YK, Kirkpatrick Roubidoux E, Francisco I, Strohmeier S, Kanekiyo M, Graham BS, Krammer F, Pardi N.
McMahon M, et al. Among authors: rijnink w.
Proc Natl Acad Sci U S A. 2022 Nov 8;119(45):e2206333119. doi: 10.1073/pnas.2206333119. Epub 2022 Nov 2.
Proc Natl Acad Sci U S A. 2022.
PMID: 36322769
Free PMC article.
Item in Clipboard
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses.
Pardi N, Carreño JM, O'Dell G, Tan J, Bajusz C, Muramatsu H, Rijnink W, Strohmeier S, Loganathan M, Bielak D, Sung MMH, Tam YK, Krammer F, McMahon M.
Pardi N, et al. Among authors: rijnink w.
Nat Commun. 2022 Aug 9;13(1):4677. doi: 10.1038/s41467-022-32149-8.
Nat Commun. 2022.
PMID: 35945226
Free PMC article.
Item in Clipboard
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.
Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreño JM, Strohmeier S, Schmitz AJ, Zafar S, Zhou JQ, Rijnink W, Alshammary H, Borcherding N, Reiche AG, Srivastava K, Sordillo EM, van Bakel H; Personalized Virology Initiative; Turner JS, Bajic G, Simon V, Ellebedy AH, Krammer F.
Amanat F, et al. Among authors: rijnink w.
Cell. 2021 Jul 22;184(15):3936-3948.e10. doi: 10.1016/j.cell.2021.06.005. Epub 2021 Jun 8.
Cell. 2021.
PMID: 34192529
Free PMC article.
Item in Clipboard
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD.
Amanat F, Thapa M, Lei T, Sayed Ahmed SM, Adelsberg DC, Carreno JM, Strohmeier S, Schmitz AJ, Zafar S, Zhou JQ, Rijnink W, Alshammary H, Borcherding N, Reiche AG, Srivastava K, Sordillo EM, van Bakel H; Personalized Virology Initiative; Turner JS, Bajic G, Simon V, Ellebedy AH, Krammer F.
Amanat F, et al. Among authors: rijnink w.
medRxiv [Preprint]. 2021 May 1:2021.03.07.21253098. doi: 10.1101/2021.03.07.21253098.
medRxiv. 2021.
PMID: 33758878
Free PMC article.
Preprint.
Item in Clipboard
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis.
Rijnink WF, Ottenhoff THM, Joosten SA.
Rijnink WF, et al.
Front Immunol. 2021 Feb 18;12:640168. doi: 10.3389/fimmu.2021.640168. eCollection 2021.
Front Immunol. 2021.
PMID: 33679802
Free PMC article.
Review.
Item in Clipboard
Cite
Cite